Seeking oesophageal (gullet) cancer patients

23rd November 2017

Bristol-Myers Squibb (BMS), the biopharmaceutical company, are keen to contact patients with oesophageal cancer patients (cancer of the gullet) and their carers.

They are seeking 4 pairs of UK patients and their carers to participate in market research interviews to help BMS understand the patient / carer experience in oesophageal cancer and identify what the unmet needs are, as well as where the key barriers to treatment are. Their aims are to:

  • Uncover how patients are talking about unmet needs by understanding their narrative, their struggles, and how they make sense of their condition and treatment.
  • Understand patient perceptions of current treatment options.
  • Identify key commonalities and differences in the experience of patients diagnosed “early stage” vs. “late stage.”

Patient profile:  BMS are seeking 2 patients who were diagnosed at the metastatic setting and 2 who were diagnosed at an earlier stage but have now advanced to metastatic disease.

The time commitment is:

  • About 10 hours total to consider both writing/thinking time to complete a type of guided journal with a series of questions in a workbook – it typically takes 1 hour a day for 5 days and 1 hour total for caregivers as well, if relevant.
  • Two of the patients might also be asked for a follow up interview (a 45min telephone conversation).

For participating in the study BMS will pay an honoraria to each couple for their time (£40/hour, so approx £400-440 per couple).

If you know of any interested patients then please get in touch with:

STUART BARBER (Policy, Advocacy and Government Affairs Manager)
T: +44 (0) 1895 52 3635
E: [email protected]

  • twitter
  • facebook
  • linkedin
  • youtube
  • tiktok
  • instagram

Read more posts...

Important: Guts UK affected by significant IT issue

Guts UK is currently experiencing a significant IT issue beyond our control, which has resulted in the loss of access to our email accounts and disruption to other systems. All members of our team have...

8th November 2024

The text IT issues affecting Guts UK are written in white on a blue background, alongside an illustration of a person sat at a desk looking at their computer.

Sharing the results from our PERT shortages survey

About PERT and the supply issues Pancreatic enzyme replacement therapy (PERT) helps people with conditions including pancreatic exocrine insufficiency (PEI), acute and chronic pancreatitis, cystic fibrosis and pancreatic cancers to absorb nutrients from food, manage...

12th November 2024